Bone biopsy trocar/ndl supfc
CPT code 20220 covers a bone biopsy performed using a trocar or needle to collect a small sample of bone tissue from a superficial (near the surface) location. This is a diagnostic procedure used to identify infections, tumors, or other bone abnormalities.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify place of service code accuracy - POS 22 (outpatient hospital) triggers facility rate of $83.78 while POS 11 (office) triggers non-facility rate of $219.96
Impact: $136.18 payment difference based solely on POS code; incorrect POS is a leading cause of overpayment recovery audits for this code
Bill imaging guidance separately when performed - if fluoroscopy (77002) or CT guidance (77012) is used, document and bill separately as these are not bundled with 20220
Impact: Additional $50-150 in reimbursement when imaging guidance is properly documented and billed; requires separate documentation of medical necessity for guidance
Document the specific bone biopsied and depth - superficial designation in 20220 is critical; deeper biopsies may qualify for higher-paying codes (20225 for deep biopsy)
Impact: Using 20225 instead of 20220 when appropriate increases reimbursement by approximately 30-40%; misclassification can result in underpayment or audit risk
Capture pathology interpretation separately - the surgical pathology exam (88305 for bone biopsy) is separately billable by the pathologist and should not be overlooked in facility coding
Impact: While not affecting surgical reimbursement, ensures complete revenue capture for facility; pathology adds $100-200 to total procedure revenue
Use diagnosis codes that support medical necessity - link to specific findings (e.g., D49.2 for neoplasm of unspecified behavior, M86.9 for osteomyelitis) rather than vague symptom codes
Impact: Reduces denial rate by 40-60%; payers frequently deny based on insufficient medical necessity when only symptom codes are used
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.